Clinical implications of changing definitions within the Gleason grading system

Nature Reviews Urology

Volumn 7, Issue 3, 2010, Pages 136-142

  Lotan, Tamara L ^a   Epstein, Jonathan I ^a  

^a JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER GRADING; CANCER GROWTH; CANCER SCREENING; CANCER STAGING; CANCER SURVIVAL; DIGITAL RECTAL EXAMINATION; FOLLOW UP; GLEASON SCORE; HISTORY OF MEDICINE; HUMAN; IMMUNOHISTOCHEMISTRY; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROSTATE ADENOCARCINOMA; PROSTATE BIOPSY; PROSTATECTOMY; REVIEW; CLASSIFICATION; CONSENSUS DEVELOPMENT; MALE; PROSTATIC NEOPLASMS; SEVERITY OF ILLNESS INDEX;

CONSENSUS DEVELOPMENT CONFERENCES AS TOPIC; HUMANS; MALE; PROSTATIC NEOPLASMS; SEVERITY OF ILLNESS INDEX;

EID: 77949423889     PISSN: 17594812     EISSN: 17594820     Source Type: Journal    
DOI: 10.1038/nrurol.2010.9     Document Type: Review

References (32)

1. Gleason, D. F. Classification of prostatic carcinomas. Cancer Chemother. Rep. 50, 125-128 (1966).
2. Gleason, D. F. & Mellinger, G. T. Prediction of prognosis for prostatic adenocarcinoma by combined histological grading and clinical staging. J. Urol. 111, 58-64 (1974).
3. Epstein, J. I., Allsbrook, W. C. Jr, Amin, M. B., Egevad, L. L. & ISUP Grading Committee. The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma. Am. J. Surg. Pathol. 29, 1228-1242 (2005).
4. Epstein, J. I. Gleason score 2-4 adenocarcinoma of the prostate on needle biopsy: a diagnosis that should not be made. Am. J. Surg. Pathol. 24, 477-478 (2000).
5. Epstein, J. I. & Netto, G. N. in Biopsy Interpretation of the Prostate Ch. 9 (Lippincott, Williams & Wilkins, Philadelphia, PA, 2008).
6. Mellinger, G. T. Prognosis of prostatic carcinoma. Recent Results Cancer Res. 60, 61-72 (1977).
7. Mellinger, G. T., Gleason, D. & Bailar, J. 3rd. The histology and prognosis of prostatic cancer. J. Urol. 97, 331-337 (1967).
8. Amin, M. B., Schultz, D. S. & Zarbo, R. J. Analysis of cribriform morphology in prostatic neoplasia using antibody to high-molecular-weight cytokeratins. Arch. Pathol. Lab. Med. 118, 260-264 (1994).
9. Gaeta, J. F., Asirwatham, J. E., Miller, G. & Murphy, G. P. Histologic grading of primary prostatic cancer: a new approach to an old problem. J. Urol. 123, 689-693 (1980).
10. Helpap, B. et al. Classification, histological and cytological grading and assessment of regression grading in prostatic carcinomas. A recommendation of the Pathologic-Urological Task Force on Prostatic Carcinoma [German]. Pathologe 6, 3-7 (1985).
11. Brawn, P. N., Ayala, A. G., von Eschenbach, A. C., Hussey, D. H. & Johnson, D. E. Histologic grading study of prostate adenocarcinoma: the development of a new system and comparison with other methods-a preliminary study. Cancer 49, 525-532 (1982).
12. Mostofi, F. K., Davis, C. J., Sesterhenn, I. A., Sobin, L. H. & Davis, C. J. World Health Organization. International Histological Classification of Tumors: Histological Typing of Prostate Tumors. 2nd edn (Springer-verlag, New York, 2002).
13. Helpap, B. & Egevad, L. The significance of modified Gleason grading of prostatic carcinoma in biopsy and radical prostatectomy specimens. Virchows Arch. 449, 622-627 (2006).
14. Billis, A. et al. The impact of the 2005 international society of urological pathology consensus conference on standard Gleason grading of prostatic carcinoma in needle biopsies. J. Urol. 180, 548-553 (2008).
15. Lange, P. H. & Narayan, P. Understaging and undergrading of prostate cancer. Argument for postoperative radiation as adjuvant therapy. Urology 21, 113-118 (1983).
16. Garnett, J. E., Oyasu, R. & Grayhack, J. T. The accuracy of diagnostic biopsy specimens in predicting tumor grades by Gleason's classification of radical prostatectomy specimens. J. Urol. 131, 690-693 (1984).
17. Mills, S. E. & Fowler, J. E. Jr. Gleason histologic grading of prostatic carcinoma. Correlations between biopsy and prostatectomy specimens. Cancer 57, 346-349 (1986).
18. Steinberg, D. M., Sauvageot, J., Piantadosi, S. & Epstein, J. I. Correlation of prostate needle biopsy and radical prostatectomy Gleason grade in academic and community settings. Am. J. Surg. Pathol. 21, 566-576 (1997).
19. San Francisco, I. F., DeWolf, W. C., Rosen, S., Upton, M. & Olumi, A. F. Extended prostate needle biopsy improves concordance of Gleason grading between prostate needle biopsy and radical prostatectomy. J. Urol. 169, 136-140 (2003).
20. Helpap, B. & Egevad, L. Modified Gleason grading. An updated review. Histol. Histopathol. 24, 661-666 (2009).
21. Fine, S. W. & Epstein, J. I. A contemporary study correlating prostate needle biopsy and radical prostatectomy Gleason score. J. Urol. 179, 1335-1339 (2008).
22. Helpap, B. & Egevad, L. Correlation of modified Gleason grading with pT stage of prostatic carcinoma after radical prostatectomy. Anal. Quant. Cytol. Histol. 30, 1-7 (2008).
23. Allsbrook, W. C. Jr et al. Interobserver reproducibility of Gleason grading of prostatic carcinoma: general pathologist. Hum. Pathol. 32, 81-88 (2001).
24. Gofrit, O. N., Zorn, K. C., Steinberg, G. D., Zagaja, G. P. & Shalhav, A. L. The Will Rogers phenomenon in urological oncology. J. Urol. 179, 28-33 (2008).
25. Miyamoto, H., Hernandez, D. J. & Epstein, J. I. A pathological reassessment of organ-confined, Gleason score 6 prostatic adenocarcinomas that progress after radical prostatectomy. Hum. Pathol. 40, 1693-1698 (2009).
26. Ward, J. F., Slezak, J. M., Blute, M. L., Bergstralh, E. J. & Zincke, H. Radical prostatectomy for clinically advanced (cT3) prostate cancer since the advent of prostatespecific antigen testing: 15-year outcome. BJU Int. 95, 751-756 (2005).
27. Berglund, R. K. et al. Radical prostatectomy as primary treatment modality for locally advanced prostate cancer: a prospective analysis. Urology 67, 1253-1256 (2006).
28. Yossepowitch, O. et al. Secondary therapy, metastatic progression, and cancer-specific mortality in men with clinically high-risk prostate cancer treated with radical prostatectomy. Eur. Urol. 53, 950-959 (2008).
29. Loeb, S. et al. What are the outcomes of radical prostatectomy for high-risk prostate cancer? Urology doi:10.1016/j.urology.2009.09.014.
30. Frank, S. J. et al. Interstitial implant alone or in combination with external beam radiation therapy for intermediate-risk prostate cancer: a survey of practice patterns in the United States. Brachytherapy 6, 2-8 (2007).
31. Latour, M. et al. Grading of invasive cribriform carcinoma on prostate needle biopsy: an interobserver study among experts in genitourinary pathology. Am. J. Surg. Pathol. 32, 1532-1539 (2008).
32. Lotan, T. L. & Epstein, J. I. Gleason grading of prostatic adenocarcinoma with glomeruloid features on needle biopsy. Hum. Pathol. 40, 471-477 (2009).